To verify the HIF-1α upregulation by HIF-PH inhibitors, the expression of HIF-1α in CD8+ T cells and colon cancer cells was evaluated following treatment with Roxadustat and Vadadustat, both of which possess iron-chelating properties. Here, CD8A is linked to malignant colon neoplasm.